CCO Oncology Podcast artwork

HCC Surveillance: Challenges and Opportunities

CCO Oncology Podcast

English - January 03, 2023 21:30 - 31 minutes - 29 MB
Courses Education Health & Fitness Medicine essential thrombocythemia myelofibrosis oncology cme skin cancer acute myeloid leukemia kidney cancer melanoma gastrointestinal cancer prostate can Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: A Patient’s Perspective on Effective Communication With the Healthcare Team: My Journey With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
Next Episode: Contemporary Approaches to Treating Polycythemia Vera: A Conversation Between Experts

In this episode, David Kaplan, MD, MSc, and Tamar Taddei, MD, discuss which patients should be screened for hepatocellular carcinoma, current surveillance recommendations, barriers to implementation, emerging biomarkers in development, and unmet needs in hepatocellular carcinoma surveillance. 

Presenters:

David E. Kaplan, MD, MSc
Associate Professor
Perelman School of Medicine
Chief, Hepatology Section 
Division of Gastroenterology and Hepatology 
University of Pennsylvania
Director of Hepatology
Corporal Michael J. Crescenz VA Medical Center
Philadelphia, Pennsylvania

Tamar Taddei, MD
Professor 
Section of Digestive Diseases 
Department of Internal Medicine
Yale School of Medicine 
Chief, GI Section 
VA Connecticut Healthcare System
West Haven, Connecticut